NCK1_HUMAN - dbPTM
NCK1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID NCK1_HUMAN
UniProt AC P16333
Protein Name Cytoplasmic protein NCK1
Gene Name NCK1
Organism Homo sapiens (Human).
Sequence Length 377
Subcellular Localization Cytoplasm. Endoplasmic reticulum. Nucleus. Mostly cytoplasmic, but shuttles between the cytoplasm and the nucleus. Import into the nucleus requires the interaction with SOCS7. Predominantly nuclear following genotoxic stresses, such as UV irradiation
Protein Description Adapter protein which associates with tyrosine-phosphorylated growth factor receptors, such as KDR and PDGFRB, or their cellular substrates. Maintains low levels of EIF2S1 phosphorylation by promoting its dephosphorylation by PP1. Plays a role in the DNA damage response, not in the detection of the damage by ATM/ATR, but for efficient activation of downstream effectors, such as that of CHEK2. Plays a role in ELK1-dependent transcriptional activation in response to activated Ras signaling. Modulates the activation of EIF2AK2/PKR by dsRNA. May play a role in cell adhesion and migration through interaction with ephrin receptors..
Protein Sequence MAEEVVVVAKFDYVAQQEQELDIKKNERLWLLDDSKSWWRVRNSMNKTGFVPSNYVERKNSARKASIVKNLKDTLGIGKVKRKPSVPDSASPADDSFVDPGERLYDLNMPAYVKFNYMAEREDELSLIKGTKVIVMEKCSDGWWRGSYNGQVGWFPSNYVTEEGDSPLGDHVGSLSEKLAAVVNNLNTGQVLHVVQALYPFSSSNDEELNFEKGDVMDVIEKPENDPEWWKCRKINGMVGLVPKNYVTVMQNNPLTSGLEPSPPQCDYIRPSLTGKFAGNPWYYGKVTRHQAEMALNERGHEGDFLIRDSESSPNDFSVSLKAQGKNKHFKVQLKETVYCIGQRKFSTMEELVEHYKKAPIFTSEQGEKLYLVKHLS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAEEVVVVA
------CCCEEEEEE
22.9622223895
12 (in isoform 2)Phosphorylation-35.9723909892
13PhosphorylationVVVAKFDYVAQQEQE
EEEEECCEECCCCEE
10.79-
21 (in isoform 2)Phosphorylation-9.1325159151
25 (in isoform 2)Phosphorylation-65.4625159151
27 (in isoform 2)Phosphorylation-59.0129507054
48PhosphorylationVRNSMNKTGFVPSNY
HCCCCCCCCCCCHHH
30.7423882029
53PhosphorylationNKTGFVPSNYVERKN
CCCCCCCHHHHHHCC
35.1823882029
55PhosphorylationTGFVPSNYVERKNSA
CCCCCHHHHHHCCCH
14.1826074081
61PhosphorylationNYVERKNSARKASIV
HHHHHCCCHHHHHHH
32.2726074081
66PhosphorylationKNSARKASIVKNLKD
CCCHHHHHHHHHHHH
30.8329514088
69UbiquitinationARKASIVKNLKDTLG
HHHHHHHHHHHHHHC
55.69-
74PhosphorylationIVKNLKDTLGIGKVK
HHHHHHHHHCCCCCC
25.8718212344
79AcetylationKDTLGIGKVKRKPSV
HHHHCCCCCCCCCCC
42.5425953088
79UbiquitinationKDTLGIGKVKRKPSV
HHHHCCCCCCCCCCC
42.54-
85PhosphorylationGKVKRKPSVPDSASP
CCCCCCCCCCCCCCC
49.6829255136
89PhosphorylationRKPSVPDSASPADDS
CCCCCCCCCCCCCCC
25.2829255136
91PhosphorylationPSVPDSASPADDSFV
CCCCCCCCCCCCCCC
25.2729255136
96PhosphorylationSASPADDSFVDPGER
CCCCCCCCCCCCCCC
27.9321945579
105PhosphorylationVDPGERLYDLNMPAY
CCCCCCCCCCCCCEE
25.3025159151
109SulfoxidationERLYDLNMPAYVKFN
CCCCCCCCCEEEEEE
2.3331801345
112PhosphorylationYDLNMPAYVKFNYMA
CCCCCCEEEEEEECC
9.7821945579
117PhosphorylationPAYVKFNYMAEREDE
CEEEEEEECCCCCCH
10.8026074081
126PhosphorylationAEREDELSLIKGTKV
CCCCCHHHCCCCCEE
26.4626074081
129UbiquitinationEDELSLIKGTKVIVM
CCHHHCCCCCEEEEE
66.86-
131PhosphorylationELSLIKGTKVIVMEK
HHHCCCCCEEEEEEE
19.6926074081
147PhosphorylationSDGWWRGSYNGQVGW
CCCEEECCCCCCEEE
13.5723663014
148PhosphorylationDGWWRGSYNGQVGWF
CCEEECCCCCCEEEE
26.5726074081
157PhosphorylationGQVGWFPSNYVTEEG
CCEEEECHHHCCCCC
31.1728450419
159PhosphorylationVGWFPSNYVTEEGDS
EEEECHHHCCCCCCC
17.0628450419
161PhosphorylationWFPSNYVTEEGDSPL
EECHHHCCCCCCCCC
20.2628787133
166PhosphorylationYVTEEGDSPLGDHVG
HCCCCCCCCCHHHHC
32.6425159151
174PhosphorylationPLGDHVGSLSEKLAA
CCHHHHCCHHHHHHH
27.8628787133
176PhosphorylationGDHVGSLSEKLAAVV
HHHHCCHHHHHHHHH
34.0928450419
178UbiquitinationHVGSLSEKLAAVVNN
HHCCHHHHHHHHHHC
39.80-
202PhosphorylationVQALYPFSSSNDEEL
EEECCCCCCCCCCCC
28.4927251275
203PhosphorylationQALYPFSSSNDEELN
EECCCCCCCCCCCCC
33.2727251275
204PhosphorylationALYPFSSSNDEELNF
ECCCCCCCCCCCCCC
47.2927251275
231UbiquitinationENDPEWWKCRKINGM
CCCHHHHHEEEECCE
25.82-
246PhosphorylationVGLVPKNYVTVMQNN
EEECCCCEEEEEECC
12.0120068231
248PhosphorylationLVPKNYVTVMQNNPL
ECCCCEEEEEECCCC
10.4127251275
256PhosphorylationVMQNNPLTSGLEPSP
EEECCCCCCCCCCCC
23.2320068231
257PhosphorylationMQNNPLTSGLEPSPP
EECCCCCCCCCCCCC
49.4129978859
262PhosphorylationLTSGLEPSPPQCDYI
CCCCCCCCCCCCCCC
39.5823403867
268PhosphorylationPSPPQCDYIRPSLTG
CCCCCCCCCCHHHCC
13.3720068231
272PhosphorylationQCDYIRPSLTGKFAG
CCCCCCHHHCCCCCC
28.8123403867
274PhosphorylationDYIRPSLTGKFAGNP
CCCCHHHCCCCCCCC
42.5429978859
286UbiquitinationGNPWYYGKVTRHQAE
CCCCCCCEEEHHHHH
25.06-
310PhosphorylationGDFLIRDSESSPNDF
CCEEEECCCCCCCCE
29.5427251275
312PhosphorylationFLIRDSESSPNDFSV
EEEECCCCCCCCEEE
55.8620068231
313PhosphorylationLIRDSESSPNDFSVS
EEECCCCCCCCEEEE
24.5425159151
318PhosphorylationESSPNDFSVSLKAQG
CCCCCCEEEEEEECC
17.4128857561
322UbiquitinationNDFSVSLKAQGKNKH
CCEEEEEEECCCCCC
31.02-
339PhosphorylationVQLKETVYCIGQRKF
EEEEEEEEEEECCCC
5.9325839225
345UbiquitinationVYCIGQRKFSTMEEL
EEEEECCCCCCHHHH
35.46-
347PhosphorylationCIGQRKFSTMEELVE
EEECCCCCCHHHHHH
29.8528450419
348PhosphorylationIGQRKFSTMEELVEH
EECCCCCCHHHHHHH
31.5628450419
357UbiquitinationEELVEHYKKAPIFTS
HHHHHHHHHCCEEEC
44.35-
358UbiquitinationELVEHYKKAPIFTSE
HHHHHHHHCCEEECC
52.83-
364PhosphorylationKKAPIFTSEQGEKLY
HHCCEEECCCCCEEE
19.7129496907
369UbiquitinationFTSEQGEKLYLVKHL
EECCCCCEEEEEEEC
49.62-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
105YPhosphorylationKinaseABL1P00519
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of NCK1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of NCK1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
EPHB1_HUMANEPHB1physical
9430661
MINK1_HUMANMINK1physical
15469942
RHG32_HUMANARHGAP32physical
12819203
MTA1_MOUSEMta1physical
11483358
MTA3_MOUSEMta3physical
11483358
SOS1_HUMANSOS1physical
10206341
DYN1_HUMANDNM1physical
10206341
SOCS1_HUMANSOCS1physical
10022833
PKN2_HUMANPKN2physical
8910519
WASL_HUMANWASLphysical
11340081
RRAS_HUMANRRASphysical
10671570
EGFR_HUMANEGFRphysical
9362449
KHDR1_HUMANKHDRBS1physical
9362449
M4K4_HUMANMAP4K4physical
9135144
LCP2_HUMANLCP2physical
10229072
SOS1_HUMANSOS1physical
7862111
CASL_HUMANNEDD9physical
8879209
FAK1_HUMANPTK2physical
8879209
DCC_HUMANDCCphysical
12149262
EGFR_HUMANEGFRphysical
1333047
PGFRB_HUMANPDGFRBphysical
1333047
TBK1_HUMANTBK1physical
7706279
SOS1_HUMANSOS1physical
8810325
PAK1_HUMANPAK1physical
11157752
SOCS7_HUMANSOCS7physical
9344857
TNFL6_HUMANFASLGphysical
11741599
M4K1_HUMANMAP4K1physical
9891069
CD3E_HUMANCD3Ephysical
12110186
FAK1_HUMANPTK2physical
11950595
PKN2_HUMANPKN2physical
10026169
PAK1_HUMANPAK1physical
10026169
SOS1_HUMANSOS1physical
10026169
EGFR_HUMANEGFRphysical
10026169
PGFRB_HUMANPDGFRBphysical
10026169
ABL1_HUMANABL1physical
11494134
CBL_HUMANCBLphysical
11494134
GAB2_HUMANGAB2physical
10391903
WASP_HUMANWASphysical
12135674
KHDR1_HUMANKHDRBS1physical
9010224
PROF1_HUMANPFN1physical
9694849
PAK1_HUMANPAK1physical
8824201
M4K1_HUMANMAP4K1physical
11279207
SPN90_HUMANNCKIPSDphysical
11278500
RASA1_HUMANRASA1physical
21664272
RL40_HUMANUBA52physical
21900206
KHDR1_HUMANKHDRBS1physical
22745667
CBL_HUMANCBLphysical
9851874
PAK1_HUMANPAK1physical
9851874
P85A_HUMANPIK3R1physical
11418612
SHIP1_HUMANINPP5Dphysical
22267732
LCP2_HUMANLCP2physical
22267732
UBS3B_HUMANUBASH3Bphysical
22267732
GRB2_HUMANGRB2physical
22267732
CBL_HUMANCBLphysical
10829062
CBL_HUMANCBLphysical
10967110
ABL1_HUMANABL1physical
10967110
TBA1A_HUMANTUBA1Aphysical
17868192
ERBB3_HUMANERBB3physical
16273093
DOK1_HUMANDOK1physical
11551902
DOK1_MOUSEDok1physical
10202139
PHC2_HUMANPHC2physical
21988832
SHAN3_HUMANSHANK3physical
21988832
CBL_HUMANCBLphysical
24287595
OLIG1_HUMANOLIG1physical
25814554
P55G_HUMANPIK3R3physical
25814554
SH21A_HUMANSH2D1Aphysical
25814554
IF2B_HUMANEIF2S2physical
11959995
APBB2_HUMANAPBB2physical
26496610
WIPF1_HUMANWIPF1physical
26496610
TRRAP_HUMANTRRAPphysical
26496610
UXT_HUMANUXTphysical
26496610
RAD54_HUMANRAD54Lphysical
26496610
WASL_HUMANWASLphysical
26496610
PAPS1_HUMANPAPSS1physical
26496610
EPN4_HUMANCLINT1physical
26496610
TRI14_HUMANTRIM14physical
26496610
ACK1_HUMANTNK2physical
26496610
UBR4_HUMANUBR4physical
26496610
RNC_HUMANDROSHAphysical
26496610
RTEL1_HUMANRTEL1physical
26496610
HEAT3_HUMANHEATR3physical
26496610
WIPF2_HUMANWIPF2physical
26496610
GHR_HUMANGHRphysical
25241761
ABL2_HUMANABL2physical
25241761
BLNK_HUMANBLNKphysical
25241761

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of NCK1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85; SER-96 AND TYR-105,AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85; SER-91 AND SER-96,AND MASS SPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85; SER-96 AND TYR-105,AND MASS SPECTROMETRY.
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells.";
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.;
J. Proteome Res. 8:3852-3861(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-105, AND MASSSPECTROMETRY.
"Phosphoproteome of resting human platelets.";
Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.;
J. Proteome Res. 7:526-534(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-105, AND MASSSPECTROMETRY.
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks.";
Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.;
Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-105, AND MASSSPECTROMETRY.
"Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules.";
Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.;
Mol. Cell. Proteomics 4:1240-1250(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-105, AND MASSSPECTROMETRY.

TOP